ArticleEnvironmental toxicology2026
Ameliorating Effect of Continuous Treatment With an Amorphous Formula of Curcumin on Maternal Imidacloprid Exposure-Induced Suppression of Hippocampal Neurogenesis in Rats.
Article in Environmental toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Maternal exposure to imidacloprid (IMI) suppresses hippocampal neurogenesis in rat offspring. This study investigated the antioxidant effects of an amorphous formula of curcumin (CUR) given at a supplement level on IMI-induced suppression of neurogenesis to clarify the toxicity mechanisms. Maternal rats were given a diet containing 750-ppm IMI and drinking water with or without 120-ppm CUR from gestational day (GD) 6 until weaning at 21 days post-delivery. Then, offspring received CUR similarly until postnatal day 77 in adulthood. At weaning, IMI had suppressed neurogenesis and synaptic plasticity in granule cells, which may be related to suppressed reelin and parvalbumin signaling of GABAergic interneurons. IMI exposure increased CD68
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.